Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.

Kostakoglu L, Fardanesh R, Posner M, Som P, Rao S, Park E, Doucette J, Stein EG, Gupta V, Misiukiewicz K, Genden E.

Oncologist. 2013;18(10):1108-17. doi: 10.1634/theoncologist.2013-0068. Epub 2013 Sep 13.

2.

Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examination.

Rangaswamy B, Fardanesh MR, Genden EM, Park EE, Fatterpekar G, Patel Z, Kim J, Som PM, Kostakoglu L.

Laryngoscope. 2013 Nov;123(11):2664-9. doi: 10.1002/lary.24077. Epub 2013 Apr 1.

PMID:
23553147
3.

Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, Pradier O, Bizais Y, Kraeber-Bodéré F, Salaun PY.

J Nucl Med. 2009 Jan;50(1):24-9. doi: 10.2967/jnumed.108.055806. Epub 2008 Dec 17.

4.

FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.

Suenaga Y, Kitajima K, Ishihara T, Sasaki R, Otsuki N, Nibu K, Minamikawa T, Kiyota N, Sugimura K.

Eur Radiol. 2016 Apr;26(4):1018-30. doi: 10.1007/s00330-015-3902-1. Epub 2015 Jul 19.

PMID:
26188656
5.

(18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.

Kim JW, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.

Br J Cancer. 2013 Dec 10;109(12):2973-9. doi: 10.1038/bjc.2013.668. Epub 2013 Oct 22.

6.

Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.

Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, Hany TF.

Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):919-27. doi: 10.1007/s00259-009-1064-6. Epub 2009 Feb 10.

PMID:
19205699
7.
8.

18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence.

Ito K, Yokoyama J, Kubota K, Morooka M, Shiibashi M, Matsuda H.

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1318-27. doi: 10.1007/s00259-010-1400-x. Epub 2010 Mar 20.

PMID:
20306040
9.

Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.

Lee JR, Choi YJ, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1020-7. doi: 10.1245/s10434-015-4689-7. Epub 2015 Jun 30.

PMID:
26122372
10.

Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.

Yao M, Graham MM, Smith RB, Dornfeld KJ, Skwarchuk M, Hoffman HT, Funk GF, Graham SM, Menda Y, Buatti JM.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1410-8.

PMID:
15590172
11.

The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.

Kao J, Vu HL, Genden EM, Mocherla B, Park EE, Packer S, Som PM, Kostakoglu L.

Cancer. 2009 Oct 1;115(19):4586-94. doi: 10.1002/cncr.24493.

12.

FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.

Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M, Fukuda H.

Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):590-5. Epub 2004 Jan 14.

PMID:
14722678
13.

18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.

Yi JS, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY, Roh JL.

J Surg Oncol. 2012 Nov;106(6):708-12. doi: 10.1002/jso.23185. Epub 2012 Jun 4.

PMID:
22674652
14.

PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient.

Dunsky KA, Wehrmann DJ, Osman MM, Thornberry BM, Varvares MA.

Laryngoscope. 2013 Sep;123(9):2161-4. doi: 10.1002/lary.23941. Epub 2013 Jul 1.

PMID:
23817791
15.

Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.

Schaarschmidt BM, Heusch P, Buchbender C, Ruhlmann M, Bergmann C, Ruhlmann V, Schlamann M, Antoch G, Forsting M, Wetter A.

Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):92-102. doi: 10.1007/s00259-015-3145-z. Epub 2015 Aug 6.

PMID:
26243264
17.

Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma.

Balogova S, Périé S, Kerrou K, Grahek D, Montravers F, Angelard B, Susini B, El Chater P, St Guily JL, Talbot JN.

Mol Imaging Biol. 2008 Nov-Dec;10(6):364-73. doi: 10.1007/s11307-008-0155-2. Epub 2008 Jul 31.

PMID:
18668293
18.

Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.

Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.

Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.

PMID:
20197344
19.

FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.

Krabbe CA, Pruim J, van der Laan BF, Rödiger LA, Roodenburg JL.

Oral Oncol. 2009 Mar;45(3):234-40. doi: 10.1016/j.oraloncology.2008.05.024. Epub 2008 Aug 19.

PMID:
18715818
20.

Surveillance for recurrent head and neck cancer using positron emission tomography.

Lowe VJ, Boyd JH, Dunphy FR, Kim H, Dunleavy T, Collins BT, Martin D, Stack BC Jr, Hollenbeak C, Fletcher JW.

J Clin Oncol. 2000 Feb;18(3):651-8.

PMID:
10653881

Supplemental Content

Support Center